Fox Chase Cancer Center — Philadelphia, Pennsylvania

Public research footprint of Fox Chase Cancer Center, compiled from the ClinicalTrials.gov public registry.

1,289

Registered studies

301

Active

121

Recruiting now

734

Completed

203

Stopped or withdrawn

Most-studied conditions

Ann Arbor Stage III Lymphocyte-Depleted Classic Hodgkin Lymphoma · Lung Non-Small Cell Squamous Carcinoma · Locally Advanced Malignant Solid Neoplasm · Metastatic Non-Cutaneous Melanoma

Recently updated registry entries

NCT03258554 — Radiation Therapy With Durvalumab or Cetuximab in Treating Patients With Locoregionally… (Completed)
NCT05142696 — A Study of [177Lu]Lu-DOTA-TATE in Newly Diagnosed ES-SCLC Patients in Combination With… (Active Not Recruiting)
NCT07185997 — Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Fox Chase Cancer Center?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.